https://www.recognizeaatd.org/
Overcome the Unknown: Increasing Awareness, Screening, and Testing of AATD
screening and testingthe unknownovercomeincreasingawareness
https://article-realm.com/article/Health-Fitness/74973-Therapeutics-for-AATD-Alpha1-Proteinase-Inhibitor-Market-Overview.html
Therapeutics for AATD: Alpha1-Proteinase Inhibitor Market Overview Article Realm.com Free Article...
Alpha1-Proteinase Inhibitor, commonly referred to as Alpha1-Antitrypsin or AAT, is a protein synthesized by the liver that plays a critical role in protecting...
market overviewtherapeuticsaatdinhibitorarticle
https://consultqd.clevelandclinic.org/where-are-they-patients-with-alpha-1-antitrypsin-deficiency-podcast
Where Are They? Patients with AATD (Podcast)
A podcast episode from Respiratory Exchange explores the true prevalence of AATD among Americans and why so many remain undetected.
patientsaatdpodcast
https://www.talk.bio/2025/09/wave-life-sciences-shares-dip-after.html
Wave Life Sciences Shares Dip After Mixed Data Update on GSK-Partnered AATD Therapy
life scienceswavesharesdipmixed
https://www.fiercebiotech.com/biotech/wave-rna-editing-restores-enzyme-alpha-1antitrypsin-deficiency-trial-investors-unimpressed
Wave reports AATD win, but investors unimpressed
Sep 3, 2025 - The biotech's stock slipped even though its RNA editing treatment restored alpha-1 antitrypsin to clinically meaningful levels.
wave reportsaatdwininvestors